Global & Trade
Learn more about our Global Affairs work.
AdvaMed®’s Top 10 Medtech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel® companies, 2022 was a…
The Global Medtech Industry: Rewiring Medtech in a Post-Pandemic World
This white paper from IQVIA – an associate member of AdvaMed® – discusses how global markets and specific therapeutic areas are poised for growth over the next decade.
ResMed CEO Mick Farrell on Leadership, Learning from Experience, and Giving Back
Mick Farrell, CEO of ResMed, joined Scott Whitaker on the Medtech POV podcast to explain what motivates him to serve patients and his community.
New Episode of Medtech POV Podcast: ResMed CEO Discusses Scaling Up Ventilator Production, Navigating Semiconductor Chips Shortages, to Put Patients First
Mick Farrell, ResMed CEO and member of the AdvaMed® board of directors, joined AdvaMed®’s Scott Whitaker on the Medtech POV podcast to discuss how an agile company with skilled staff…
AdvaMed® Joins Ministerial Forum on Global Supply Chain Resilience
The Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, took part in the Biden Administration’s 2022 Global Supply Chain Ministerial to discuss key strategies…
New AdvaMed®, Deloitte Semiconductor Chip Study Looks at Impact of Shortages on Medtech
Deloitte released the findings of a follow-up survey of medical device manufacturers that found since the initial survey in July 2021 that semiconductor disruptions continue across multiple chip types and…
Why Patients Deserve Priority in Global Semiconductor Chips Shortage
Frans van Houten, CEO of Royal Philips, explains the potentially dire consequences of unchecked chip shortages for monitoring unborn babies, treating sudden cardiac arrest patients, assessing the vital signs of…